Peripherally Inserted Central Catheters Market Size & Share, By Product (Power Injected PICC, Conventional PICC, Neonatal PICC), Lumen (Single, Double, Multiple), Application, (Chemotherapy, Long-term IV Infusion, Parenteral Nutrition) End-Use - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Market Outlook:

Peripherally Inserted Central Catheters Market size is predicted to grow from USD 1.41 Billion in 2024 to USD 98.55 Billion by 2034, reflecting a CAGR of over 9.9% from 2025 through 2034. The industry revenue is forecasted to reach USD 1.53 billion in 2025.

• Base Year Value (2024): USD 1.41 Billion
• CAGR (2025-2034): 9.9%
• Forecast Year Value (2034): USD 98.55 Billion
• Historical Data Period: 2021-2024
• Largest Region: North America
• Forecast Period: 2025-2034

Market Dynamics:

Growth Drivers & Opportunities

The Peripherally Inserted Central Catheters (PICC) market is primarily driven by the increasing demand for minimally invasive procedures in healthcare. As hospitals and outpatient facilities focus on enhancing patient comfort and reducing recovery times, the adoption of devices like PICCs has gained momentum. These catheters facilitate prolonged intravenous access for therapies such as chemotherapy and nutritional support, which is particularly crucial for patients with chronic illnesses. Furthermore, advancements in catheter design, which enhance safety and ease of insertion, are opening new avenues for market growth. Innovative features, such as anti-microbial coatings and ultrasound-guided placement technologies, are attracting healthcare providers seeking to minimize complications and improve patient outcomes.

Another significant growth driver is the rising incidence of chronic diseases, including cancer and cardiovascular disorders that require long-term intravenous therapy. As a result, there’s an increasing need for reliable access solutions. The aging population, with its higher predisposition to such conditions, further fuels demand within this market. Additionally, the growing preference for home healthcare solutions is propelling the use of PICCs for outpatient treatment, enabling patients to receive care in the comfort of their homes. This shift not only eases the burden on healthcare facilities but also contributes to the overall market expansion.

Moreover, strategic collaborations and partnerships among manufacturers to develop and launch advanced PICC devices also present lucrative growth opportunities. As competition intensifies, companies are innovating their product offerings, which could lead to more effective and safer catheterization methods. Investment in research and development to create smart catheters that integrate with digital health technologies is another promising avenue. These advancements not only improve monitoring and patient safety but also align with the broader trend of digital transformation in healthcare.

Report Scope

Report Coverage	Details
Segments Covered	Product, Lumen, Application, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Access Vascular, Inc., AngioDynamic, Inc., Argon Medical, B. Braun Medical Ltd, Becton, Dickinson and Company, Biowy Corporation, Cardinal Health, Inc., Footprint Medical Incorporated, ICU Medical, Inc., Kimal Plc, Medi-Tech Devices, Teleflex Incorporated

Industry Restraints:

Despite the promising growth of the PICC market, several restraints could hinder its expansion. One notable challenge is the risk of catheter-related complications such as infections and thrombosis, which may result in extended hospital stays or secondary treatments. These complications can lead to negative patient outcomes, ultimately impacting the perception and acceptance of PICC devices within clinical settings. Additionally, the costs associated with managing these complications may discourage some healthcare providers from recommending PICCs, particularly in cost-sensitive environments.

Another restraint is the stringent regulatory frameworks governing medical devices. The approval process for new PICC designs can be lengthy and complex, which may delay the introduction of innovative products to the market. This is compounded by the need for comprehensive clinical data to demonstrate efficacy and safety, which requires significant investment and time. Furthermore, fluctuations in healthcare policies and reimbursement frameworks could lead to uncertainties in market growth, as changes can influence funding for catheterization procedures.

Lastly, the availability of alternative vascular access devices, such as central lines and peripheral catheters, poses a competitive threat to the PICC market. Healthcare providers may opt for these alternatives based on specific patient needs or procedural preferences. Additionally, a lack of trained personnel for proper PICC placement and management can further limit the usage of these catheters, creating a barrier to optimal market penetration.

Regional Forecast:

North America

The North American Peripherally Inserted Central Catheters (PICC) market is primarily driven by a strong healthcare infrastructure, high prevalence of chronic diseases, and advanced technological innovations. The United States is expected to lead the region, benefiting from its extensive hospital networks and growing demand for outpatient treatment options. Canada is also seeing increased adoption of PICCs, influenced by rising healthcare expenditure and initiatives aimed at improving patient care. The rapid development of novel catheter technologies and an aging population will contribute to market growth throughout this region.

Asia Pacific

In the Asia Pacific region, countries such as China, Japan, and South Korea are poised for significant growth in the Peripherally Inserted Central Catheters market. China, with its vast population and increasing healthcare investments, is expected to emerge as the largest market due to the rising incidence of diseases requiring long-term catheterization. Meanwhile, Japan’s advanced medical technology and high standards of healthcare are likely to support a stable market expansion. South Korea is also expected to show rapid growth, attributed to its innovative healthcare practices and a rising geriatric population, leading to heightened demand for effective vascular access solutions.

Europe

The European market for Peripherally Inserted Central Catheters is projected to demonstrate substantial growth, particularly in major economies like the United Kingdom, Germany, and France. The UK is anticipated to showcase a growing market size, driven by increasing surgical procedures and the adoption of less invasive medical technologies. Germany stands out with its robust healthcare system and emphasis on research and development, enhancing the accessibility of advanced catheter solutions. France, characterized by its high quality of healthcare services and rising patient volumes, is also expected to contribute positively to the expansion of the PICC market across the continent.

Segmentation Analysis:

In terms of segmentation, the global Peripherally Inserted Central Catheters market is analyzed on the basis of Product, Lumen, Application, End-Use.

Product Segmentation

The Peripherally Inserted Central Catheters (PICC) market is segmented primarily by product type, which includes single-lumen, double-lumen, and multi-lumen catheters. Among these, multi-lumen catheters are anticipated to exhibit the largest market size due to their ability to facilitate various treatments simultaneously, making them particularly appealing for patients requiring complex care regimens. Additionally, the dual-lumen segment is gaining momentum as it allows for both infusion and blood sampling without compromising the patient's comfort, leading to a projected increase in demand over time.

Lumen Segmentation

In terms of lumen configuration, the market is divided into single-lumen, double-lumen, and multi-lumen catheters. The multi-lumen category is expected to lead in terms of growth potential, driven by the increasing need for comprehensive treatment options within a single catheter system. This versatile design supports multiple therapies, enhancing patient convenience and reducing the number of catheter insertions required. Furthermore, double-lumen catheters are also anticipated to see significant growth, particularly in outpatient settings where patient management is critical.

Application Segmentation

The applications of PICCs are varied, encompassing oncology, antibiotic therapy, parenteral nutrition, and others. The oncology segment is predicted to dominate the market, driven by the rising prevalence of cancer globally and the increasing need for long-term venous access for chemotherapy. Furthermore, the antibiotic therapy segment is also poised for notable growth as antibiotic treatments often necessitate extended intravenous access, propelling demand for effective catheter solutions.

End-Use Segmentation

The end-use segments for PICCs include hospitals, ambulatory surgical centers, and home healthcare settings. Hospitals are expected to hold the largest share of the market due to the high volume of patients requiring intravenous therapies and the advanced infrastructure available to support complex medical procedures. However, the home healthcare segment is forecasted to witness the fastest growth. This trend is driven by a shift towards patient-centered care and the increasing preference for at-home treatment options, allowing patients to receive necessary therapies in a more comfortable and familiar environment.

Competitive Landscape:

The competitive landscape in the Peripherally Inserted Central Catheters (PICC) market is characterized by a mix of established medical device manufacturers and emerging players focused on innovation and enhancing patient safety. Major companies are investing heavily in research and development to create advanced catheters that minimize infection rates and improve patient comfort, in response to the growing demand for minimally invasive procedures. Factors such as regulatory changes, funding for healthcare infrastructure, and increasing incidence of chronic diseases drive competition among key players, who strive to expand their market share through strategic partnerships and acquisitions. The rise of telemedicine and home healthcare further influences market dynamics, pushing companies to develop solutions tailored for at-home patient care.

Top Market Players

1. Becton, Dickinson and Company

2. Boston Scientific Corporation

3. Medtronic plc

4. Smiths Medical

5. Teleflex Incorporated

6. Baxter International Inc.

7. C. R. Bard, Inc. (acquired by BD)

8. Vygon SA

9. Argon Medical Devices, Inc.

10. NIPRO Corporation